In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 3, 1996, Pages 399-408

  Giacometti, Andrea ^a,b   Cirioni, Oscar ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ARTEMISIN; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; DAPSONE; MACROLIDE; MINOCYCLINE; PAROMOMYCIN; PYRIMETHAMINE; ROXITHROMYCIN; SPIRAMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; CULTURE MEDIUM; FECES; GROWTH INHIBITION; MONOLAYER CULTURE; NONHUMAN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ARTEMISININS; ATOVAQUONE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DAPSONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; LACTONES; MACROLIDES; MINOCYCLINE; NAPHTHOQUINONES; PYRIMETHAMINE; SESQUITERPENES;

EID: 0029841982     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.3.399     Document Type: Article

References (25)

1. Cama, V. A., Marshall, M. M., Shubitz, L. F., Ortega, Y. R. & Sterling, C. R. (1994). Treatment of acute and chronic Criptosporidium parvum infections in mice using darithromycin and 14-OH clarithromycin. Journal of Eukaryotic Microbiology 41, 25S.
2. Cantin, L. & Chamberland, S. (1993). In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 37, 1993-6.
3. Chang, H. R., Arsenijevic, D., Comte, R., Polak, A., Then, R. L. & Pechere, J. C. (1994). Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 38, 1803-7.
4. Chio, L. C. & Queener, S. F. (1993). Identification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductase. Antimicrobial Agents and Chemotherapy 37, 1914-23.
5. Current, W. L. & Haynes, T. B. (1984). Complete development of Cryptosporidium in cell culture. Science 224, 603-5.
6. Derouin, F., Caroff, B., Chau, F., Prokocimer, P. & Pocidalo, J. J. (1992). Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrobial Agents and Chemotherapy 36, 2852-5.
7. Derouin, F. & Chastang, C. (1989). In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 33, 1753-9.
8. Payer, R. & Ellis, W. (1994). Qinghaosu (artemisin) and derivates fail to protect neonatal BALB/c mice against Cryptosporidium parvetn (Cp) infection. Journal of Eukaryotic Microbiology 41, 41S.
9. Flanigan, T. P., Aji, T., Marshall, R., Soave, R., Aikawa, M. & Kaetzel, C. (1991). Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line. Infection and Immunity 59, 234-9.
10. Goozé, L., Kim, K., Petersen, C., Gut, J. & Nelson, R. G. (1991) Amplification of a Cryptosporidium parvum gene fragment enconding thymidylate synthase. Journal of Protozoology 38, S56-8.
11. Lacassin, F., Schaffe, D., Perronne, C., Longuet, P., Leport, C. & Vilde, J. L. (1995). Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 39, 276-7.
12. Ma, P. & Soave, R. (1983). Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea. Journal of Infectious Diseases 147, 824-8.
13. McDonald, V., Stables, R., Warhurst, D. C., Barer, M. R., Blewett, D. A., Chapman, H. D. et al. (1990). In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrobial Agents and Chemotherapy 34, 1498-500.
14. Petersen, C. (1992). Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clinical Infectious Diseases 15, 903-9.
15. Pfefferkorn, E. R. & Borotz, S. E. (1994). Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. Antimicrobial Agents and Chemotherapy 38, 31-7.
16. Portnoy, D., Whiteside, M. E., Buckley, E. & Macleod, C. L. (1984). Treatment of intestinal cryptosporidiosis with spyramycin. Annales of Internal Medicine 101, 202-4.
17. Rehg, J. E. (1994). A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. Journal of Infectious Diseases 170, 934-8.
18. Rehg, J. E. (1991). Anti-cryptosporidial activity of macrolides in immunosuppressed rats. Journal of Protozoology 38, S228-30.
19. Rohlman, V. C., Kuhls, T. L., Mosier, D. A., Crawford, D. L., Hawkins, D. R., Abrams V. L. et al. (1993). Therapy with atovaquone for Cryptosporidium parvum infection in neonatal severe combined immunodeficiency mice. Journal of Infectious Diseases 168, 258-60.
20. Romand, S., Pudney, M. & Derouin, F. (1993). In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 37, 2371-8.
21. Schwartz, R. M. & Dayhoff, M. O. (1978). Origins of prokaryotes, eukaryotes, mitochondria, and chloroplasts. Science 199, 395-403.
22. Vargas, S. L., Shenep, J. L., Flynn, P. M., Pui, C. H., Santana, V. M. & Hughes, W. T. (1993). Azythromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer. Journal of Pediatrics 123, 154-6.
23. Verdon, R., Polianski, J., Gaudebout, C., Marche, C., Carry, L. & Pocidalo, J. J. (1994). Evaluation of curative anticryptosporidial activity of paramomycin in a dexamethasone-treated rat model. Antimicrobial Agents and Chemotherapy 38, 1681-2.
24. Weikel, C., Lazenby, A., Belitsos, P., McDewitt, M., Fleming, E. H. & Barbacci, M. (1991) Intestinal injury associated with spiramycin therapy of Cryptosporidum infection in AIDS. Journal of Protozoology 38, S147.
25. White, A. C. Jr., Chappel, C. L., Hayat, C. S., Kimball, K. T., Flanigan, T. P. & Goodgame, R. W. (1994). Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. Journal of Infectious Diseases 170, 419-24.